From online randomized controlled trials to participant preference studies: morphing the San Francisco Stop Smoking site into a worldwide smoking cessation resource

Ricardo F Muñoz, Adrian Aguilera, Stephen M Schueller, Yan Leykin, Eliseo J Pérez-Stable, Ricardo F Muñoz, Adrian Aguilera, Stephen M Schueller, Yan Leykin, Eliseo J Pérez-Stable

Abstract

Background: Internet interventions have the potential to address many of the health problems that produce the greatest global burden of disease. We present a study illustrating this potential. The Spanish/English San Francisco Stop Smoking Internet site, which yielded quit rates of 20% or more at 12 months in published randomized controlled trials (RCTs), was modified to make it accessible to Spanish- and English-speaking smokers 18 years of age or older anywhere in the world.

Objective: To illustrate that Internet interventions designed to conduct RCTs can be adapted to serve as universal health care resources. We also examine quit rates obtained in the current participant preference study (in which users could choose from all elements tested in previous RCTs) to determine whether they differ from the quit rates found in the RCTs.

Methods: We modified the San Francisco Stop Smoking Internet site so that, instead of being randomly assigned to a specific intervention, participants could personalize the site by choosing among nine site elements (eg, stop smoking guide, reminder emails, journal, mood management intervention, or virtual group). Participants completed a baseline assessment, and reported smoking and mood data at 1-, 3-, 6-, and 12-month follow-ups. We assessed the modified website's reach and outcomes (quit rates), and compared the quit rates of the current participant preference study with those of the previous RCTs.

Results: In the first year of recruitment, 94,158 individuals from 152 countries and territories visited the site; 13,488 participants left some data; 9173 signed consent; 7763 completed the baseline survey; and 1955, 1362, 1106, and 1096 left 1-, 3-, 6-, and 12-month data, respectively. Observed quit rates were 38.1% (n = 668), 44.9% (n = 546), 43.6% (n = 431), and 45.4% (n = 449), respectively. The current participant preference study yielded higher observed quit rates (odds ratio 1.30) than the previous RCT when controlling for individuals' demographic and smoking characteristics.

Conclusions: After strict RCTs are completed, Internet intervention sites can be made into worldwide health intervention resources without reducing their effectiveness.

Trial registration: Clinicaltrials.gov NCT00721786; https://ichgcp.net/clinical-trials-registry/NCT00721786 (Archived by WebCite at http://www.webcitation.org/66npiZF4y).

Conflict of interest statement

None declared.

Figures

Figure 1
Figure 1
Progression of participants through the San Francisco Stop Smoking participant preference site, with follow-up at 1 month (1m), 3 months (3m), 6 months (6m), and 12 months (12m).
Figure 2
Figure 2
Observed quit rates by study for the San Francisco Stop Smoking participant preference study and previous randomized controlled trials (RCTs). The outcomes of the current participant preference site, as compared with the RCT with live cohort maintenance follow-up methods ([7], N = 1000), a fully automated RCT without live follow-up ([11], N = 16,430), and condition 4, the condition in that same automated RCT that included all site elements, which approximates the current site, but without the participant preference component ([11], n = 4105). Shaded areas indicate missing data. Observed Quit is defined as the number reporting not smoking divided by number reporting smoking status (smoking or not smoking). Thus, it does not impute values for missing data.

References

    1. Moss WG. George Mason University's History News Network. 2009. Nov 07, [2011-05-24]. Is Health Care a Human Right? .
    1. United Nations. 1948. [2011-08-03]. The Universal Declaration of Human Rights
    1. Lewis LT. Huffington Post. 2011. Jan 20, [2011-05-24]. Honoring a Dream for Health Care Justice .
    1. World Health Organization. 2008. [2011-08-03]. WHO Report on the Global Tobacco Epidemic, 2008: The MPOWER Package .
    1. WHO Media Centre World Health Organization. 2011. Feb, [2011-05-24]. Tobacco Fact Sheet no 339 .
    1. Muñoz RF, Lenert LL, Delucchi K, Stoddard J, Perez JE, Penilla C, Pérez-Stable EJ. Toward evidence-based Internet interventions: A Spanish/English Web site for international smoking cessation trials. Nicotine Tob Res. 2006 Feb;8(1):77–87. doi: 10.1080/14622200500431940.X446716T2418L625
    1. Muñoz RF, Barrera AZ, Delucchi K, Penilla C, Torres LD, Pérez-Stable EJ. International Spanish/English Internet smoking cessation trial yields 20% abstinence rates at 1 year. Nicotine Tob Res. 2009 Sep;11(9):1025–34. doi: 10.1093/ntr/ntp090.ntp090
    1. Pérez-Stable EJ, Sabogal F, Marín G, Marín BV, Otero-Sabogal R. Evaluation of “Guia para Dejar de Fumar," a self-help guide in Spanish to quit smoking. Public Health Rep. 1991;106(5):564–70.
    1. Muñoz RF, Marín BV, Posner SF, Pérez-Stable EJ. Mood management mail intervention increases abstinence rates for Spanish-speaking Latino smokers. Am J Community Psychol. 1997 Jun;25(3):325–43.
    1. Institute of Medicine . Crossing the Quality Chasm: A New Health Care System for the 21st Century. Washington, DC: National Academy Press; 2001.
    1. Leykin Y, Aguilera A, Torres LD, Pérez-Stable EJ, Muñoz RF. Interpreting the outcomes of automated internet-based randomized trials: example of an International Smoking Cessation Study. J Med Internet Res. 2012;14(1):e5. doi: 10.2196/jmir.1829. v14i1e5
    1. National Cancer Institute . Guia para Dejar de Fumar. NIH Publication No. 02-3001. Washington, DC: US Government Printing Office; 2002.
    1. National Cancer Institute. 2010. Mar 7, [2011-12-03]. Programa Latino para Dejar de Fumar .
    1. Lenert L, Muñoz RF, Perez JE, Bansod A. Automated e-mail messaging as a tool for improving quit rates in an internet smoking cessation intervention. J Am Med Inform Assoc. 2004;11(4):235–40. doi: 10.1197/jamia.M1464. M1464
    1. Hall SM, Muñoz RF, Reus VI, Sees KL, Duncan C, Humfleet GL, Hartz DT. Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo-controlled study. J Consult Clin Psychol. 1996 Oct;64(5):1003–9.
    1. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991 Sep;86(9):1119–27.
    1. Muñoz RF. University of California, San Francisco, School of Medicine, Latino Mental Health Research Program. [2012-04-17]. The Mood Screener: a Major Depression Episode Screener .
    1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. 4th edition, text revision. Washington, DC: American Psychiatric Association; 2000.
    1. Muñoz RF, McQuaid JR, González GM, Dimas J, Rosales VA. Depression screening in a women's clinic: using automated Spanish- and English-language voice recognition. J Consult Clin Psychol. 1999 Aug;67(4):502–10.
    1. Spitzer RL, Williams JB, Kroenke K, Linzer M, deGruy FV, Hahn SR, Brody D, Johnson JG. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA. 1994 Dec 14;272(22):1749–56.
    1. Vázquez FL, Muñoz RF, Blanco V, López M. Validation of Muñoz's Mood Screener in a nonclinical Spanish population. Eur J Psychol Assess. 2008;24:57–64. doi: 10.1027/1015-5759.24.1.57.
    1. Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385. doi: 10.1177/014662167700100306.
    1. Schroeder SA. What to do with a patient who smokes. JAMA. 2005 Jul 27;294(4):482–7. doi: 10.1001/jama.294.4.482.294/4/482
    1. Hall SM, Lightwood JM, Humfleet GL, Bostrom A, Reus VI, Muñoz R. Cost-effectiveness of bupropion, nortriptyline, and psychological intervention in smoking cessation. J Behav Health Serv Res. 2005;32(4):381–92.00075484-200510000-00005
    1. Murray CJL, Lopez AD. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability From Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Cambridge, MA: Harvard School of Public Health on behalf of the World Health Organization and the World Bank; 1996.

Source: PubMed

3
订阅